Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
0.655
-0.010 (-1.50%)
Jan 17, 2025, 4:00 PM EST - Market closed

Enzo Biochem Revenue

Enzo Biochem had revenue of $6.21M in the quarter ending October 31, 2024, a decrease of -20.41%. This brings the company's revenue in the last twelve months to $30.31M, down -4.56% year-over-year. In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.

Revenue (ttm)
$30.31M
Revenue Growth
-4.56%
P/S Ratio
1.11
Revenue / Employee
$222,897
Employees
136
Market Cap
34.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jul 31, 202431.91M846.00K2.72%
Jul 31, 202331.06M-1.58M-4.85%
Jul 31, 202232.64M-85.09M-72.27%
Jul 31, 2021117.73M41.71M54.87%
Jul 31, 202076.02M-5.15M-6.34%
Jul 31, 2019 Pro Pro Pro
Jul 31, 2018 Pro Pro Pro
Jul 31, 2017 Pro Pro Pro
Jul 31, 2016 Pro Pro Pro
Jul 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings